Heart rate control for permanent atrial fibrillation and heart failure
Part of Heart & circulation clinical trials.
This trial studies whether a strategy to regularize (control) heart rate can improve outcomes in people who have permanent atrial fibrillation and heart failure. It focuses on people with recent heart-failure hospitalization and checks several heart, kidney, and health-condition limits to keep the study safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have permanent atrial fibrillation (a lasting irregular heart rhythm).
- You were hospitalized for heart failure at least once in the last 12 months.
- Your heart pumping strength is above 40% (left ventricular ejection fraction > 40%).
- Your resting heart rate is 110 beats per minute or lower.
- Your NT-proBNP blood test is at least 900 in the past 30 days.
- You’re 18 or older and able to understand the study and consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two types of heart pacing procedures for people with heart failure and atrial fibrillation (irregular heartbeat). One approach involves disabling the natural electrical pathway between the upper and lower heart chambers and using a pacemaker to regulate heartbeats; the other uses a special pacemaker that helps both chambers work together. The goal is to reduce symptoms and hospitalizations.
This study compares two treatments for people with atrial fibrillation and heart failure: one is a procedure to fix the irregular heartbeat (AF ablation), and the other involves a different type of pacing for the heart. It aims to find which approach helps you feel better and stay out of the hospital.
This trial tests a special pacing method (conduction system pacing) combined with a small ablation to control heart rate in people with permanent atrial fibrillation and advanced heart failure. It aims to improve symptoms and potentially avoid the need for a heart transplant or LVAD.
This trial tests if a pacemaker plus an ablation procedure can improve heart failure symptoms in people with atrial fibrillation. It is for those with moderate to severe heart failure who are already on the right medications.
This trial studies a heart pacing approach in people with heart failure symptoms despite preserved heart pumping. It aims to see whether changing heart timing can improve how you feel and how your heart works during exercise.
This study tests a new way to place pacing leads (thin wires) in the heart to help it beat more effectively in patients with atrial fibrillation (irregular heartbeat) and heart failure. The goal is to improve how well the heart pumps blood and reduce symptoms.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.